Picture of Veracyte logo

VCYT — Veracyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Veracyte Inc reports results for the quarter ended in June - Earnings Summary

* Veracyte Inc  VCYT.OQ  reported a quarterly adjusted loss
of 13 cents​​ per share for the quarter ended in June. The mean
expectation of ten analysts for the quarter was for a loss of 25
cents per share.
* Revenue rose 166.2% to $55.11 million from a year ago; 
analysts expected $48.06 million. 
* The mean earnings estimate of analysts had fallen by
about 172.4% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Veracyte Inc shares had fallen by 1.3% this quarter and
lost 19.4% so far this year.
* The company reported a quarterly loss of $9.04 million.
* Wall Street's median 12-month price target for Veracyte Inc is
$55.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated July 30 at 03:13 a.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Veracyte

See all news